2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS
- 22 September 2021
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (3) , 1090-1091
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell LymphomaMolecular Imaging and Biology, 2021
- Neurological toxicities associated with chimeric antigen receptor T-cell therapyBrain, 2019
- Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor –T-cell therapy in B-cell non-Hodgkin lymphomasCytotherapy, 2018
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell LymphomaNew England Journal of Medicine, 2017
- Advances in Diagnosis and Management of Diffuse Large B-cell LymphomaClinical Lymphoma Myeloma and Leukemia, 2017
- Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 studyBlood, 2017